Back to list

Happy New Year! Welcome back to this month’s MedscapeLIVE! Cardiology E-News. This month the faculty of Medscape’s Going Back to the Heart of Cardiology 2022 once again come together and share insights on cardiology happenings in 2022 that represent a critical step forward in patient care. Read on for an amazing collection of advances over the past year that these docs—and you—will be able to utilize to better care for your patients.

In our last issue, the faculty of Medscape’s Going Back to the Heart of Cardiology 2022 came together and shared a few pearls from their presentations, as well as shared their most interesting cases of 2022—which made for pretty interesting and informative reading! If you missed that interview, you can view it here. You canalso watch video recap

Also check out this issue’s Pulse, with articles from the Journal of the American Heart Association, Circulation, European Heart Journal, Journal of the American College of Cardiology, Cardiology News, and New England Journal of Medicine.


Housekeeping on CME 2023—Add this to your calendar now and sign up for updates:

Going Back to the Heart of Cardiology Conference (4th Annual)

Saturday-Monday December 8-10, 2023; Anaheim, California

· Cath Lab Challenge!: An Exclusive Virtual Interventional Session: Interventional cath lab teams from Columbia, Duke, Stanford, Vermont present/discuss innovative cases of best practice approaches to conquering novel and complex coronary, structural, and peripheral disease challenges.

· Sessions 1-6: Cardiopulmonary Failure; Atherosclerosis and Thrombosis; and Cardiometabolic Disease; Electrical Failure; Valvular Disease: Special Topics in Cardiology

· View Faculty & Agenda: https://na.eventscloud.com/website/36345/savethedate/

· Access CME from HOC 2022: https://na.eventscloud.com/website/36345/home/

·     View 2022 HOC Recap—Click HERE!

Thank you to these doctors for sharing their time and expertise as faculty and in this interview. Don’t forget to register for and access Medscape’s Going Back to the Heart of Cardiology 2022 conference if you missed it—go online now here and gain the best CME opportunity available! Happy New Year, and please contact me at colleen@cmhadvisors.com with any comments and/or suggestions! –Colleen Hutchinson

The Best Advances of 2022…And What’s to Come!

Colleen: What’s happened in cardiology in 2022 that feels like a big step forward for patient care? 

Dr. Robert Eckel: New data demonstrating the tremendously beneficial effects (~20-25% mean weight loss) of 2 drugs for obesity: high dose semaglutide (Novo Nordisk) and tirzepatide (Lilly).

Dr. Anne Curtis: The impact of SGLT2 inhibitors on improving outcomes in patients with heart failure with a preserved ejection fraction is an important step forward in patient care. In the patient, treatment for these patients was mainly limited to the use of diuretics, as no other therapies had been shown to have an impact on outcomes.

Dr. Thomas Maddox: We finally have effective therapies for HFpEF!

Dr. Javed Butler: Both American and European guidelines giving SGLT2i class 1 indication for HFrEF.

Dr. Pamela Morris: The CHAP Trial that clarified the safety and efficacy of more aggressive treatment of hypertension in pregnancy.

Dr. Brett Sperry: The first adult cardiac xenotransplant occurred at the University of Maryland.

Dr. Geoff Barnes: I’m particularly excited to have novel lipid therapies for patients with familial hyperlipidemia and severe ASCVD. In addition to PCSK9-inhibitors, which we’ve gotten comfortable using over the past few years, we now have small interfering RNA molecules (incliserin) that can be administered twice a year. This should dramatically improve adherence to lipid-lowering therapies for our most at-risk patients.

Dr. Nasrien Ibrahim: The addition of SGLT2i to the toolbox of GDMT for HFrEF and how this 4-drug regimen significantly reduced morbidity and mortality.

The Pulse

European Heart Journal Article: Hot topics in ischaemic heart disease: polygenic risk scores, coronary microvascular dysfunction, myocardial injury, and diagnostic role of imaging


Circulation: Arrhythmia and Electrophysiology Article: Substrate Mapping Alters Ventricular Tachycardia Inducibility


JAMA Cardiology Quick Uptakes: The COVID Heart—One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks


Cardiology News: Five thoughts on the Damar Hamlin collapse


Save the Date: The 2023 4th Annual Going Back to the Heart of Cardiology:


JACC Original Investigation: Regional Antibiotic Delivery for Implanted Cardiovascular Electronic Device Infections


NEJM Original Article: Trial of an Intervention to Improve Acute Heart Failure Outcomes


Medical Intelligence Quiz: Fast Facts Friday